Epstein-Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseases

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
82 Downloads (Pure)

Abstract

B cells expressing the transcription factor T-bet are found to have a protective role in viral infections, but are also considered major players in the onset of different types of autoimmune diseases. Currently, the exact mechanisms driving such 'atypical' memory B cells to contribute to protective immunity or autoimmunity are unclear. In addition to general autoimmune-related factors including sex and age, the ways T-bet+ B cells instigate autoimmune diseases may be determined by the close interplay between genetic risk variants and Epstein-Barr virus (EBV). The impact of EBV on T-bet+ B cells likely relies on the type of risk variants associated with each autoimmune disease, which may affect their differentiation, migratory routes and effector function. In this hypothesis-driven review, we discuss the lines of evidence pointing to such genetic and/or EBV-mediated influence on T-bet+ B cells in a range of autoimmune diseases, including systemic lupus erythematosus (SLE) and multiple sclerosis (MS). We provide examples of how genetic risk variants can be linked to certain signaling pathways and are differentially affected by EBV to shape T-bet+ B-cells. Finally, we propose options to improve current treatment of B cell-related autoimmune diseases by more selective targeting of pathways that are critical for pathogenic T-bet+ B-cell formation.

Original languageEnglish
Pages (from-to)66-74
Number of pages9
JournalImmunology Letters
Volume261
Early online date13 Jul 2023
DOIs
Publication statusPublished - Sept 2023

Bibliographical note

Funding Information:
We thank the Nationaal MS Fonds and Stichting MS Research for supporting our research.

Publisher Copyright:
© 2023 The Author(s)

Fingerprint

Dive into the research topics of 'Epstein-Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseases'. Together they form a unique fingerprint.

Cite this